Objective To evaluate the reliability of metabolic and pathologic parameters in the high fat diet-induced nonalcoholic fatty liver disease (NAFLD) rat model using a gastric perfusion method.Methods Forty-seven male Wistar rats were randomly assigned to either the normal control group (N) or the NAFLD model group (M) .There was no significant difference in body weight between the two groups.All the rats were housed under specific pathogen-free (SPF) conditions and acclimated with a normal diet for one week.Afterwards, the M group was administered a high fat diet by gastric perfusion, and the N group was administered 0.95% NS.Rats from both groups were sacrificed at the end of the 4th, 8th, and 12th week for analysis.Body length and weight was recorded for each rat, as well as the liver weight for calculating the liver Index (LI) .Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured by standard biochemical methods.Formalin-fixed liver sections were stained with hematoxylin-eosin and were graded for the degree of fatty composition and inflammation.Results Two rats died during the experiment, so that only 45 were included in the analysis.The M group showed pathological changes that were typical of NAFLD, and the degree of fat degeneration was homogeneous.Compared with the N group, the M group had significantly higher LI (P=0.000) , ALT level (P=0.006) , and AST level (P=0.000) .Conclusion A NAFLD model can be successfully induced by 12 weeks of gastric perfusion with high fat diet in adult rats.The metabolic and pathologic parameters produced by this method are consistent with NAFLD.
[1]聂小燕,张瑜,毛新民,等.非酒精性脂肪肝大鼠模型的建立[J].新疆中医药,2007 , 25 (2) ;7-9.
|
[2]钱晓武,范建高,汪晓红.改良蛋氨酸胆碱缺乏饮食喂养的非酒精性脂肪性肝炎大鼠模型的建立[J].世界华人消化杂志,2007,15 (28) :983一989.
|
[3]孙大裕.脂肪肝动物模型的研究进展[J].中华消化杂志,2002,22 (5) :305一306.
|
[4] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南 (2010修订版) [J].中华肝脏病杂志,2010,18 (3) :163一166.
|
[5]苏慧敏,张知新,潘琳,等.高脂饮食诱导幼鼠脂肪肝模型的建立及其相关代谢研究[J].中华肝脏病杂志,2010, 18 (1) ;54-58.
|
[6]Valenti L, Fracanzani AL, Dongiovanni P,et al. Tummor necroses factor alpha promoter poly-morPhisms and insulin resistance in non-alcoholic fatty liver disease[J].Gastroentr erology, 2002,122 (2) :274一280.
|
[7]Hatsugai K, Ohkohchi N,Fukumori T, et al. Mechanism of Primary graftnon function in a rat model for fatty liver trans plantation[ J].Transpl Int, 2000,13 (suppl1) :s583-589.
|
[8]Ackerman Zvi,Herman Oron,Grozovski M,et al. Fructose-inaucea fatty liver disease hepatic effects of blood pressure and plasma triglyceride reduuction[ J].Hypertension,2005,45 (5) :1012-1018.
|
[9]Terrazos-Luch J,Corona Garcia S, Zentellade PI na M,et al.Butylated hydroxytoluene prevents hepatic damage induced by food oil[J].Proe west pharmaeol Soc, 1997,40 ; 97-99.
|
[10]Zhang BH,Weltman M,Farrel GC. Does steatohepatitis impair liver regeneration? A study in a dietary model of nonalco holic Steatohepatitis in rats[J].Gastroenterol Hepatol,1999,14 (2) :133-137.
|
[11]Leclerca I,Horsmans Y, Desager JP, et al. Dietary restriction of energy and sugar results in a reduction in human cytochrome P450-2E1 activity[J].Br J Nutr, 1999, 82 (4) :257-262.
|
[1] | Qingqing ZHANG, Ying QU, Xiaobo CAI, Lungen LU. Research advances in animal models of cholestatic liver disease[J]. Journal of Clinical Hepatology, 2023, 39(7): 1754-1760. doi: 10.3969/j.issn.1001-5256.2023.07.035 |
[2] | Xiaofei SHANG, Xiuhui LI. Advances in the experimental research on traditional Chinese medicine against liver fibrosis[J]. Journal of Clinical Hepatology, 2023, 39(2): 249-259. doi: 10.3969/j.issn.1001-5256.2023.02.001 |
[3] | Yulong YANG, Taohua WEI, Wenming YANG, Wenjie HAO, Yue YANG, Nannan QIAN, Xiang LI, Hailin JIANG. Research advances in animal models of Wilson's disease[J]. Journal of Clinical Hepatology, 2022, 38(5): 1169-1174. doi: 10.3969/j.issn.1001-5256.2022.05.041 |
[4] | Meng XIA, Yuhao SUN, Meng WANG, Jing LENG. Research advances in commonly used animal models of primary hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(8): 1938-1942. doi: 10.3969/j.issn.1001-5256.2021.08.042 |
[5] | Fuli LONG, Yong LIN, Ziming PENG, Feng FENG, Jianling ZHANG, Dewen MAO, Ailing WEI. Research advances in animal models of acute liver failure[J]. Journal of Clinical Hepatology, 2021, 37(1): 204-208. doi: 10.3969/j.issn.1001-5256.2021.01.045 |
[6] | Li Yang, Shu DeJun, Peng CiJun, Feng ZanJie, Mei Yong, Xiong Kun. Effect of erythropoietin on the mRNA expression of apoptosis genes bcl-2 and bax in rats with fatty liver disease after hepatic ischemia-reperfusion injury[J]. Journal of Clinical Hepatology, 2019, 35(1): 157-160. doi: 10.3969/j.issn.1001-5256.2019.01.030 |
[7] | Chen XiaoQing, Ren YuFei, Kong WeiZong, Wang YingChun. Effect of salvianolic acid B on oxidative stress in a cell model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(10): 2175-2181. doi: 10.3969/j.issn.1001-5256.2018.10.022 |
[8] | Yan Rong, Niu ChunYan, Yu Lu, Tian Yu. Interaction between autophagy and lipid metabolism in cell models of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(10): 1981-1986. doi: 10.3969/j.issn.1001-5256.2017.10.027 |
[9] | Zhou QiFeng, Ren Li, Zhang LingQiang, Fan HaiNing. Research advances in animal models of hepatic alveolar echinococcosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2247-2250. doi: 10.3969/j.issn.1001-5256.2017.11.044 |
[10] | Zhu JuanJuan, Zhou MingYu, Cheng MingLiang. Effect of blueberry and probiotics on expression of PNPLA3 and SREBP-1c in rats with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(9): 1778-1784. doi: 10.3969/j.issn.1001-5256.2016.09.031 |
[11] | Wang Peng, Zhang ZhiQiao, Kang KaiFu, Wu GuoBiao. Classification tree model analysis of influencing factors for hepatocyte steatosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(3): 476-479. doi: 10.3969/j.issn.1001-5256.2016.03.015 |
[12] | Liu Tao, Xu QiuLing, Zhao Yan. Expression of Toll-like receptor 4 in rat model of nonalcoholic fatty liver disease induced by hyperlipidemia[J]. Journal of Clinical Hepatology, 2015, 31(12): 2073-2076. doi: 10.3969/j.issn.1001-5256.2015.12.021 |
[13] | Xiong Yan, Zhang ZhiJuan, Liu Peng, Wang Ya. Efficacy of Chaowei Zhikangyin in treatment of rat model of non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(1): 78-81. doi: 10.3969/j.issn.1001-5256.2015.01.017 |
[14] | Zhang Yu, Cheng Jun. Hepatitis C virus related fatty liver[J]. Journal of Clinical Hepatology, 2015, 31(7): 1034-1037. doi: 10.3969/j.issn.1001-5256.2015.07.009 |
[15] | Huang HaiYan, Xin YongNing, Jiang Man, Jin WenWen, Jiang XiangJun, Xuan ShiYing. Research advances in animal models of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(9): 948-953. doi: 10.3969/j.issn.1001-5256.2014.09.028 |
[16] | Xu YuWu, Liu YingZi, Fan JianGao, Yang Lin. Preliminary study on quantification of ultrasonographic classification of fatty liver [J]. Journal of Clinical Hepatology, 2010, 26(3): 267-268+280. |
[17] | Zhang Wei, Chen Ming, Cui Tao. Therapeutical and preventative effect of β-carotene on hepatic fibrosis in mice[J]. Journal of Clinical Hepatology, 2007, 23(4): 260-262. |